Lineage Cell Therapeutics, Inc. Quarterly Return On Assets in % from Q1 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Lineage Cell Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from Q1 2012 to Q2 2024.
  • Lineage Cell Therapeutics, Inc. Return On Assets for the quarter ending June 30, 2024 was -23.1 %, a 25.9% decline year-over-year.
  • Lineage Cell Therapeutics, Inc. annual Return On Assets for 2023 was -19.9 %, a 1.32% decline from 2022.
  • Lineage Cell Therapeutics, Inc. annual Return On Assets for 2022 was -19.6 %, a 35.1% increase from 2021.
  • Lineage Cell Therapeutics, Inc. annual Return On Assets for 2021 was -30.3 %, a 62% decline from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -23.1 -4.76 -25.9% Apr 1, 2024 Jun 30, 2024
Q1 2024 -22.1 -3.44 -18.4% Jan 1, 2024 Mar 31, 2024
Q4 2023 -19.9 -0.26 -1.32% Oct 1, 2023 Dec 31, 2023
Q3 2023 -20.3 +13.1 +39.2% Jul 1, 2023 Sep 30, 2023
Q2 2023 -18.4 +16.2 +46.9% Apr 1, 2023 Jun 30, 2023
Q1 2023 -18.7 +14.6 +43.8% Jan 1, 2023 Mar 31, 2023
Q4 2022 -19.6 +10.6 +35.1% Oct 1, 2022 Dec 31, 2022
Q3 2022 -33.4 -23.8 -249% Jul 1, 2022 Sep 30, 2022
Q2 2022 -34.6 -24.5 -243% Apr 1, 2022 Jun 30, 2022
Q1 2022 -33.3 -21.2 -175% Jan 1, 2022 Mar 31, 2022
Q4 2021 -30.3 -11.6 -62% Oct 1, 2021 Dec 31, 2021
Q3 2021 -9.56 +14.1 +59.6% Jul 1, 2021 Sep 30, 2021
Q2 2021 -10.1 +19.3 +65.7% Apr 1, 2021 Jun 30, 2021
Q1 2021 -12.1 +32.8 +73% Jan 1, 2021 Mar 31, 2021
Q4 2020 -18.7 -10.8 -137% Oct 1, 2020 Dec 31, 2020
Q3 2020 -23.6 +13 +35.4% Jul 1, 2020 Sep 30, 2020
Q2 2020 -29.4 -49.6 -245% Apr 1, 2020 Jun 30, 2020
Q1 2020 -44.9 -84.6 -213% Jan 1, 2020 Mar 31, 2020
Q4 2019 -7.89 +28.9 +78.6% Oct 1, 2019 Dec 31, 2019
Q3 2019 -36.6 +14.4 +28.3% Jul 1, 2019 Sep 30, 2019
Q2 2019 20.3 +101 Apr 1, 2019 Jun 30, 2019
Q1 2019 39.7 +116 Jan 1, 2019 Mar 31, 2019
Q4 2018 -36.8 -26.7 -265% Oct 1, 2018 Dec 31, 2018
Q3 2018 -51 -75.7 -307% Jul 1, 2018 Sep 30, 2018
Q2 2018 -81.2 -118 -319% Apr 1, 2018 Jun 30, 2018
Q1 2018 -76 -143 -214% Jan 1, 2018 Mar 31, 2018
Q4 2017 -10.1 -38.5 -135% Oct 1, 2017 Dec 31, 2017
Q3 2017 24.7 +1.09 +4.63% Jul 1, 2017 Sep 30, 2017
Q2 2017 37.1 +59.2 Apr 1, 2017 Jun 30, 2017
Q1 2017 66.8 +132 Jan 1, 2017 Mar 31, 2017
Q4 2016 28.4 +87 Oct 1, 2016 Dec 31, 2016
Q3 2016 23.6 +82.1 Jul 1, 2016 Sep 30, 2016
Q2 2016 -22.1 +33.2 +60% Apr 1, 2016 Jun 30, 2016
Q1 2016 -65.1 -7.26 -12.5% Jan 1, 2016 Mar 31, 2016
Q4 2015 -58.6 -1.29 -2.25% Oct 1, 2015 Dec 31, 2015
Q3 2015 -58.5 +18.2 +23.7% Jul 1, 2015 Sep 30, 2015
Q2 2015 -55.3 +31.7 +36.5% Apr 1, 2015 Jun 30, 2015
Q1 2015 -57.9 +37.1 +39.1% Jan 1, 2015 Mar 31, 2015
Q4 2014 -57.3 +49.9 +46.5% Oct 2, 2014 Dec 31, 2014
Q3 2014 -76.7 +12.6 +14.1% Jul 1, 2014 Sep 30, 2014
Q2 2014 -87 -10.8 -14.2% Apr 1, 2014 Jun 30, 2014
Q1 2014 -95 -24 -33.9% Jan 1, 2014 Mar 31, 2014
Q4 2013 -107 -46 -75.1% Sep 29, 2013 Dec 31, 2013
Q3 2013 -89.3 -36.7 -69.7% Jul 1, 2013 Sep 30, 2013
Q2 2013 -76.2 -31.9 -71.8% Apr 1, 2013 Jun 30, 2013
Q1 2013 -70.9 -32.6 -85% Jan 1, 2013 Mar 31, 2013
Q4 2012 -61.2 Oct 1, 2012 Dec 31, 2012
Q3 2012 -52.6 Jul 1, 2012 Sep 30, 2012
Q2 2012 -44.4 Apr 1, 2012 Jun 30, 2012
Q1 2012 -38.3 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.